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Abstract : 
Human infection with avian influenza H5N1 is an emerging infectious disease characterized by respiratory symptoms and a 
high fatality rate. Hemagglutinin and neuraminidase are the two surface proteins responsible for infection by influenza virus. 
Till date, neuraminidase has been the major target for antiviral drugs. In the present study we chose hemagglutinin protein as it 
mediates the binding of the virus to target cells through sialic acid residues on the host cell-surface. Hemagglutinin of H5 avian 
influenza (PDB ID: 1JSN) was used as the receptor protein. Ligands were generated by structure-based de novo approach and 
virtual screening of ZINC database. A total of 11,104 conformers were generated and docked into the receptor binding site 
using ‘High Throughput Virtual Screening’. We proposed potential lead molecules against the receptor binding site of 
hemagglutinin based on the results obtained from in silico docking and hydrogen bond interaction between the ligand and the 
1JSN protein molecule. We found sialic acid derivative 1 to be the lead molecules amongst the ligands generated by structure 
based de novo approach. However the molecules obtained from ZINC database were showing better docking scores as well as 
conserved hydrogen bond interactions. Thus we proposed ZINC00487720 and ZINC00046810 as potential lead molecules that 
could be used as an inhibitor to the receptor binding site of hemagglutinin. They could now be studied in vivo to validate the in 
silico results.  
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Background: 
Influenza virus belongs to the Orthomyxoviridae family, 
which consists of four genera: Influenza A virus, Influenza 
B Virus, Influenza C virus and Thogotovirus [1] Influenza 
A virions are enveloped and contain eight segments of 
single-stranded, negative-sense RNA, which encode 11 
proteins [1]. The Influenza A viral envelope has the surface 
glycoproteins, hemagglutinin (HA) and neuraminidase 
(NA), as the major antigenic determinants of influenza 
viruses. There are 16 known HA antigenic subtypes (H1 to 
H16) all of which are found in aquatic birds; however 
sustained epidemics in humans have been limited to H1, H2 
and H3 subtypes [2]. Nine NA subtypes are known (N1 to 
9) of which only the N1 and N2 subtypes are circulating in 
human populations [1]. NA functions to release viruses 
attached to the host cell receptors and allow progeny 
virions to escape; thus, facilitating virus spread. 
Hemagglutinin (HA) is responsible for binding of virions to 
host cell receptors and for fusion between the virion 
envelope and the host cell [3]. HA molecules are 
homotrimers consisting of a globular head and a stalk; the 
head is made up of HA1 subunit and contains the receptor 
binding cavity. The stalk consists of the HA2 subunits and 
part of HA1 [3]. HA from avian and human influenza 
viruses preferentially bind sialic acid molecules with 
specific oligosacharide side chains, alpha 2, 3 and alpha 2, 
6 linkages, respectively [1]. 
 
In the recent past, avian influenza virus particularly H5N1 
has become a major concern as an emerging respiratory 
virus. This virus was normally endemic in aquatic birds, 
but they crossed the species barrier in 1997 in Hongkong 
[4, 5] leading to 6 human fatalities among 18 isolated cases. 
As of 14
th December 2007, 340 cases and 208 deaths due to 
H5N1 have been reported from all over the world to the 
World Health Organization. 
 
Currently, two licensed influenza antiviral agents are 
recommended for use in the United States during the 2007-
08 influenza season: oseltamivir and zanamivir. These are 
chemically related antiviral medications known as 
neuraminidase inhibitors that have activity against both 
influenza A and B viruses [6]. However, no inhibitor 
molecule is available against the HA protein of influenza 
virus till date. 
 
In the present study, we analyzed the binding site of avian 
H5 hemagglutinins (HAs) from avian influenza virus to 
human cell receptor analogs. We studied the docking 
interaction of derivatives of sialic acid, galactose and N-
acetyl glucosamine molecules at the active site of avian H5 
hemagglutinins. In addition, we had chosen molecules from 
a non-commercial small molecules database (ZINC) and 
studied their docking interaction at the active site of H5. 
From this study, we proposed lead molecules that 
competitively bind the active site of HA, prevent its 
attachment to the host cell surface moieties, and thus might 
serve as a good antiviral drug to control influenza virus 
infection.  
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Methodology: 
Protein structure  
Three-dimensional structure of hemagglutinin H5 (PDB ID: 
1JSN) from influenza A virus strain 
A/DUCK/SINGAPORE/3/97 solved by X-ray 
crystallography at 2.4Å was retrieved from the Protein Data 
Bank [7].  It consists of two protein chains: chain A (325 
residues), chain B (176 residues) and a ligand (Chain M) 
with o-sialic acid (SIA), d- galactose (GAL) and n-acetyl-
d-glucosamine (NAG). The molecule 1JSN contains 216 
waters of crystallization. 
 
Protein structure preparation 
The protein structure 1JSN was fixed by assigning bond 
orders, adding hydrogens, identifying chain information, 
hetero groups and water molecules. All the water molecules 
were deleted except for the 25
th HOH molecule, which was 
found to stabilize the interaction of the ligand (SIA, GAL 
and NAG – chain M) at the binding site of chain A (Figure 
1a).  Finally, the hydrogen bonds were optimized and the 
structure was minimized to 0.30 RMSD. 
 
De novo ligand building 
We used Ligbuilder 1.2 to build ligand molecules from 
SIA, GAL and NAG within the binding pocket of 1JSN [8]. 
The protein molecule 1JSN was kept rigid, however the 
flexibility of the ligand molecule was considered. We 
defined the starting point or seed structure by retaining the 
core structure of the ring of SIA, GAL and NAG and 
replacing the groups attached to the core of the ring with H 
atoms (Figure 2a, Figure 2b, Figure 2c). These H atoms 
served as growing sites for building ligand molecules. 
Fragments from the library containing simple hydrocarbon 
chains, amines, alcohols, and even single rings were added 
to these growing sites. We generated a set of 500 ligand 
molecules each from SIA, GAL and NAG. The parameters 
used in generating ligand molecules were as follows: MW: 
160-480; logP: -0.4 to 5.6; Hbond donor 1-5; Hbond 
acceptor: 1 to 10. Babel 1.6 an open source program was 
used to convert PDB format to mol2 format and vice versa. 
 
Virtual screening of ligands 
ZINC database containing over 4.6 million compounds in 
ready-to-dock, 3D formats was used for virtual screening 
[9]. ZINC database was searched using the SMILE script 
(C1CCOCC1) of tetrahydropyran structure (Figure 2d) and 
900 lead molecules were retrieved. 
 
Ligand preparation 
Ligands obtained from ZINC database and those built using 
Ligbuilder1.2 were prepared for docking by generating 
states at a target pH of 7.0 ± 2.0. Force field used was 
OPLS_2005. For each state of ligand, a maximum of 32 
stereoisomers were generated by retaining the specific 
chirality, of which only one low energy ring conformation 
was chosen per ligand. This work was carried out using 
Schrodinger software. 
 
Docking of ligands  
The prepared ligands were docked into the binding site of 
1JSN using the GLIDE module of Schrodinger. The grid 
was generated around this receptor binding site of 1JSN 
(Figure 1b) to define the space for docking of our ligand 
molecules.  
For prepared sets of ligands, GlideScore (GScore) was 
given by: GScore = a * vdW + b * Coul + Lipo + Hbond + 
Metal + BuryP + RotB + Site, where, vdW   = van der 
Waals energy; Coul = Coulomb energy; Lipo = Lipophilic 
contact; HBond = Hydrogen-bonding; Metal = Metal-
binding; BuryP = Penalty for buried polar groups; RotB = 
Penalty for freezing rotatable bonds; Site = Polar 
interactions in the active site and the coefficients of vdW 
and Coul were: a = 0.065, b = 0.130 for Standard Precision 
(SP) Glide 
 
Results and discussion: 
Most attention has been directed toward the type A 
influenza viruses because they alone have the potential for 
major antigenic shift and resultant pandemic spread. 
Hemagglutinin protein of influenza A virus is a viable 
target for the discovery and development of small molecule 
inhibitors of virus growth. In the present study, we 
analyzed the receptor-binding site of hemagglutinin chain 
A (1JSN) for its affinity to various ligand molecules.  
 
According to a previous study 191 amino acid sequences of 
HA from influenza virus A belonging to all known HA 
subtypes were compared. The emphasis was given on 
functional sites (receptor-binding cavity with its right and 
left edges) and degree of their conservation in each 
subtype. It was shown that despite low degree of sequence 
similarity, the active site is well conserved [10]. Also it was 
established by earlier studies that GLN residue plays an 
important role in the host range restriction [11]. In 
accordance to them our results showed the core of 1JSN, 
H5 receptor binding site consisted of GLU 186 (OE1), 
GLN 222 (OE1), and VAL (O) 131 residues. These 
correspond to atom number 1485, 1764 and 1033 in the pdb 
entry of 1JSN. We retained only the 25
th water molecule at 
the receptor binding site for docking studies as it was found 
to stabilize the interaction of the ligand molecule. 
 
We had strictly followed Lipinski's rule of five while 
designing and screening the ligands. We used a molecular 
weight range of 160-480 in generating the ligands because 
of Lipinski's second rule with regard to drugs size 
selectivity on their permeation across cellular membranes 
[12]. We selected a range of logP from 0.4 to 5.6 because 
most drugs have a logP value around 3 [13]. We generated 
a total number of 11,104 ligand conformers (2476 from 500 
Sialic acid, 3516 from 500 Galactose, 2537 from 500 NAG 
and 2575 from 900 lead molecules from ZINC database) 
for studying the docking interaction at the receptor binding 
site of HA. 
 
We had screened the obtained ligand conformers by high 
throughput virtual screening for extremely accurate binding 
mode predictions using GLIDE module. GLIDE module 
was used as it provided consistently high enrichment at 
every level. Each of the ligand conformer was tested at the 
binding site and a docking score was obtained. We 
observed that hydrogen bond was the stabilizing force in 
this protein-ligand interaction. Hence, we computed the 
hydrogen bond interactions of the ligand with the receptor 
binding site of 1JSN protein chain A.  
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amongst the ligands designed de novo GAL derivatives had 
the highest docking scores, followed by NAG and SIA 
derivatives. The docking score was computed by 
considering parameters like van der Waals energy, 
Coulomb energy, lipophilic contact, Hydrogen-bonding, 
penalty for buried polar groups, penalty for freezing 
rotatable bonds and polar interactions in the active site. 
Based on the docking scores, it was clear that GAL 
derivatives were better as inhibitors than NAG derivatives, 
which in turn were better than SIA derivatives.  
 
At this point, we computed the atomic interaction 
(hydrogen bond) of these ligands with the residues present 
at the receptor binding site of 1JSN. It was observed a 
hydrogen bond exists between atom 1764 from GLN 222 of 
chain A and sialic acid derivative 1. This interaction was 
also found between atom 1764 from GLN 222 of chain A 
and chain M of 1JSN. This in silico docking indicated that 
the relative position of the hydrogen-bonding site of the 
ligand is reasonably well matched to the receptor-binding 
site. Thus sialic acid derivative 1 could be one of the lead 
molecules which could competitively bind to the receptor- 
binding site of HA (chain A). Another significant 
observation was that NAG derivative 1 & 2 forms 
hydrogen bonds with the atom 1486(OE2) of GLU186 of 
chain A. This observation was also supported by a previous 
study stating influenza virus utilizes sialic acid as an initial 
receptor [14]. 
Studies show that the receptor for haemagglutinin is the 
terminal sialic acid residue of host cell surface 
sialyloligosaccharides, while sialidase (neuraminidase) 
catalyses the hydrolysis of terminal sialic acid residues 
from sialyloligosaccharides. Extensive crystallographic 
studies of both these proteins have revealed that the 
residues that interact with the sialic acid are strictly 
conserved. Therefore, these proteins make attractive targets 
for the design of drugs to halt the progression of the virus 
[15]. 
 
However the docking studies of ligand molecules obtained 
by screening of ZINC database gave higher docking scores 
compared to the ligands obtained from SIA, GAL and NAG 
derivatives.  The best docking scores were obtained for 2-
(hydroxymethyl)-6-(4-methylphenoxy)-tetrahydropyran-3, 
4, 5-triol (ZINC00487720) and 2 - (p-tolylaminomethyl) 
tetrahydropyran-2, 3, 4, 5-tetrol (ZINC00046810) (Figure 
3). The atom number 1764 (OE1 GLN A 222) was found to 
be involved in stabilizing the ligand interaction at the 
receptor-binding site through hydrogen bond. Again this 
was found to be conserved between chain M - chain A of 
1JSN, ZINC00487720- chain A and ZINC00046810 - chain 
A. Thus both from docking scores and conserved hydrogen 
bond interactions noted we found the ZINC compounds to 
be potent lead molecule which could be a better inhibitor 
than sialic acid derivatives.  
 
 
Figure 1: (a) The hydrogen bonds between the ligand, 25th HOH and chain A receptor binding site were represented by 
dotted yellow lines. The atom wise interactions were listed below (atom numbers were taken from PDB ID: 1JSN). (b) Grid 
generation step: the figure shows the grid box generated at active site of chain A (ribbons) in presence of 25th HOH (red and 
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Figure 2: The carbohydrate molecules and the corresponding seed structures are shown in a, b and c. The tetrahydropyran 
structure is shown in d. 
 
 
Figure 3: The GlideScore (docking score) is -4.76 for Sialic acid derivative 1 (a) and -4.72 for Sialic acid derivative 2 (b). 
The GlideScore is -5.73 for Galactose derivative 1 (c) and -5.61 for Galactose derivative 2 (d). The GlideScore is -5.55 for 
NAG derivative 1 (e) and -5.48 for NAG derivative 2 (f). The GlideScore is -6.59 for ZINC00487720 (g) and -6.57 for 
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It was shown that the monosaccharide sialic acid cannot 
account for the molecular determinant of virus receptor-
binding specificity in the context of the whole 
sialyloligosaccharide receptor. On the other hand, 
neuraminidase inhibition efforts using sialylmimetics have 
resulted into two antiinfluenza drugs, zanamivir and 
oseltamivir, which have been shown to reduce both the 
severity and duration of influenza illness. Nevertheless, the 
usage of monomeric sialylmimetics requires relatively large 
amounts of expensive compounds, which may also induce 
virus resistance and side effect. Therefore, it is critical to 
develop new antiinfluenza drugs and improve the current 
antiinfluenza drugs [16]. 
 
Thus current means of prevention of influenza virus 
infection are not entirely satisfactory because of their 
limited efficacy. A recent study reports ClO(2) gas could 
therefore be useful as a preventive means against influenza 
in places of human activity without necessitating 
evacuation  [17]. Another study reports aptamer to be a 
promising candidate for treatment and prophylaxis of 
influenza virus infections [18].  
 
Conclusion: 
Hemagglutinin is the primary determinant of host range 
because of its role in host cell recognition and attachment. 
Molecules obtained by screening ZINC database were 
found to be better inhibitors than those derived from the 
NAG, GAL and SIA molecules. Hence we proposed 
ZINC00487720 and ZINC00046810 as potent lead 
molecules as they could competitively inhibit the binding 
of HA to the host cell receptor. The results obtained from 
the present study provided a step toward the preparedness 
of pandemic flu. The proposed lead molecules could be 
either used alone or in combination with neuraminidase 
inhibitors to treat viral influenza infection after in vivo 
testing. 
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